Unique ID issued by UMIN | UMIN000026790 |
---|---|
Receipt number | R000030747 |
Scientific Title | The effect of continuous epidural block in acute herpes zoster and post-herpetic neuralgia |
Date of disclosure of the study information | 2017/06/30 |
Last modified on | 2017/08/02 11:16:04 |
The effect of continuous epidural block in acute herpes zoster and post-herpetic neuralgia
The effect of continuous epidural block in zoster
The effect of continuous epidural block in acute herpes zoster and post-herpetic neuralgia
The effect of continuous epidural block in zoster
Asia(except Japan) |
patients with zoster associated pain
Medicine in general | Anesthesiology |
Others
NO
We aim to investigate whether continuous epidural block is effective for acute and chronic phase of herpes zoster.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
pain relief score (VAS reduction)
complete remission rate, recurrence rate
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Medicine | Device,equipment |
epidural group: zoster patients received the current standard treatment for herpes and continuous epidural block for 14 days (continuous epidural block : continuous infusion of 4mL/h of 0.1% ropivacaine).
medical group: zoster patients received the current standard treatment for herpes (oral administration of 800 mg acyclovir, 1 times daily for 7 days if the rash had been present for less than 72 hour and analgesics as needed).
20 | years-old | <= |
80 | years-old | > |
Male and Female
1) acute herpes zoster patients
2) PHN patients
1) past or current conditions that could affect the interpretation of the study results, safety, and subject participation including neurological, psychological, cardiac, hepatic, hematological, muscular, dermatological, or genital problems, cancer, or an immunocompromised state; 2) dermatological diseases other than PHN; 3) a medical history of a recent major procedure or surgery; 4) major pain with a cause other than PHN; 5) the presence of a medical device implanted for neuropathic pain such as a spinal cord stimulator, intrathecal pump, or peripheral nerve stimulator; 6) a medical history of spinal bone surgery, which could complicate catheter migration or application; 7) lactating or pregnant women; and 8) patients judged as inappropriate candidates for study participation by the investigator.
332
1st name | |
Middle name | |
Last name | Sang Sik Choi |
Korea University Guro Hospital
Department of Anesthesiology and Pain Medicine
148, Gurodong-ro, Guro-gu, Seoul, Korea
8226261870
clonidine@empal.com
1st name | |
Middle name | |
Last name | Jung Eun Kim |
Korea University Guro Hospital
Department of Anesthesiology and Pain Medicine
148, Gurodong-ro, Guro-gu, Seoul, Korea
8226261870
geri200@gmail.com
Korea University
Korea University
Self funding
NO
2017 | Year | 06 | Month | 30 | Day |
Unpublished
Completed
2008 | Year | 01 | Month | 01 | Day |
2008 | Year | 01 | Month | 01 | Day |
2017 | Year | 03 | Month | 30 | Day |
2017 | Year | 08 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030747
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |